Show simple item record

dc.contributor.authorCombi, Z
dc.contributor.authorPotor, L
dc.contributor.authorNagy, P
dc.contributor.authorSikura, KÉ
dc.contributor.authorDitrói, T
dc.contributor.authorJurányi, EP
dc.contributor.authorGalambos, K
dc.contributor.authorSzerafin, T
dc.contributor.authorGergely, P
dc.contributor.authorWhiteman, M
dc.contributor.authorTorregrossa, R
dc.contributor.authorDing, Y
dc.contributor.authorBeke, L
dc.contributor.authorHendrik, Z
dc.contributor.authorMéhes, G
dc.contributor.authorBalla, G
dc.contributor.authorBalla, J
dc.date.accessioned2023-08-16T14:18:57Z
dc.date.issued2023-02-08
dc.date.updated2023-08-16T13:38:36Z
dc.description.abstractHydrogen sulfide (H2S) was previously revealed to inhibit osteoblastic differentiation of valvular interstitial cells (VICs), a pathological feature in calcific aortic valve disease (CAVD). This study aimed to explore the metabolic control of H2S levels in human aortic valves. Lower levels of bioavailable H2S and higher levels of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) were detected in aortic valves of CAVD patients compared to healthy individuals, accompanied by higher expression of cystathionine γ-lyase (CSE) and same expression of cystathionine β-synthase (CBS). Increased biogenesis of H2S by CSE was found in the aortic valves of CAVD patients which is supported by increased production of lanthionine. In accordance, healthy human aortic VICs mimic human pathology under calcifying conditions, as elevated CSE expression is associated with low levels of H2S. The expression of mitochondrial enzymes involved in H2S catabolism including sulfide quinone oxidoreductase (SQR), the key enzyme in mitochondrial H2S oxidation, persulfide dioxygenase (ETHE1), sulfite oxidase (SO) and thiosulfate sulfurtransferase (TST) were up-regulated in calcific aortic valve tissues, and a similar expression pattern was observed in response to high phosphate levels in VICs. AP39, a mitochondria-targeting H2S donor, rescued VICs from an osteoblastic phenotype switch and reduced the expression of IL-1β and TNF-α in VICs. Both pro-inflammatory cytokines aggravated calcification and osteoblastic differentiation of VICs derived from the calcific aortic valves. In contrast, IL-1β and TNF-α provided an early and transient inhibition of VICs calcification and osteoblastic differentiation in healthy cells and that effect was lost as H2S levels decreased. The benefit was mediated via CSE induction and H2S generation. We conclude that decreased levels of bioavailable H2S in human calcific aortic valves result from an increased H2S metabolism that facilitates the development of CAVD. CSE/H2S represent a pathway that reverses the action of calcifying stimuli.en_GB
dc.description.sponsorshipEötvös Loránd Research Networken_GB
dc.description.sponsorshipHungarian Governmenten_GB
dc.description.sponsorshipEuropean Unionen_GB
dc.description.sponsorshipEuropean Social Funden_GB
dc.description.sponsorshipMinistry of Innovation and Technology of Hungaryen_GB
dc.identifier.citationVol. 60, article 102629en_GB
dc.identifier.doihttps://doi.org/10.1016/j.redox.2023.102629
dc.identifier.grantnumber11003en_GB
dc.identifier.grantnumberOTKA-K 132828en_GB
dc.identifier.grantnumberGINOP-2.3.2-15-2016-00043en_GB
dc.identifier.grantnumberEFOP-3.6.2-16-2017-00006en_GB
dc.identifier.grantnumber2020-4.1.1-TKP2020en_GB
dc.identifier.grantnumberTKP2021-EGA-18en_GB
dc.identifier.urihttp://hdl.handle.net/10871/133796
dc.identifierORCID: 0000-0002-6583-6779 (Whiteman, Matthew)
dc.language.isoenen_GB
dc.publisherElsevieren_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/36780769en_GB
dc.rights© 2023 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).en_GB
dc.subjectArteriosclerosisen_GB
dc.subjectChronic kidney diseaseen_GB
dc.subjectHydrogen sulfideen_GB
dc.subjectMitochondrial H(2)S catabolismen_GB
dc.subjectPhosphateen_GB
dc.subjectValvular inflammationen_GB
dc.subjectVascular calcificationen_GB
dc.titleHydrogen sulfide as an anti-calcification stratagem in human aortic valve: Altered biogenesis and mitochondrial metabolism of H2S lead to H2S deficiency in calcific aortic valve diseaseen_GB
dc.typeArticleen_GB
dc.date.available2023-08-16T14:18:57Z
dc.identifier.issn2213-2317
exeter.article-number102629
exeter.place-of-publicationNetherlands
dc.descriptionThis is the final version. Available on open access from Elsevier via the DOI in this record. en_GB
dc.descriptionData availability: No data was used for the research described in the article.en_GB
dc.identifier.journalRedox Biologyen_GB
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2023-02-06
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2023-02-08
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2023-08-16T14:12:18Z
refterms.versionFCDVoR
refterms.dateFOA2023-08-16T14:18:58Z
refterms.panelAen_GB
refterms.dateFirstOnline2023-02-08


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2023 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).
Except where otherwise noted, this item's licence is described as © 2023 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).